A Non-toxic Treatment for Many Forms of Cancer

Researchers at the University of Alberta made their incredible cancer fighting DCA informaton public over 3 years ago. The public, however, still seems to be in the dark about this potentially brilliant cancer cure.
Health Canada gave their approval two years ago to proceed with the human clinical trials.
These expensive clinical trials are more difficult than usual to proceed with as there are no patents for DCA, dichloroacetate, and thus no potential billions of profits to be had. Many interested groups have stepped up to the plate and contributed funding to the University of Alberta Department of Medicine where the focus of this reaearch is (funding by agencies, such as the Canadian Institutes for Health Research (CIHR), the Canada Foundation for Innovation, the Canada Research Chairs program and the Alberta Heritage Foundation for Medical Research).
The researchers believe they may soon have more conclusive results.
DCA dichloroacetate, is an odourless, colourless, inexpensive, relatively non-toxic, substance.
Dr. Evangelos Michelakis, a professor at U of A in Edmonton, has shown that DCA causes regression in several cancers, including lung and breast. He and his colleagues, including post-doctoral fellow Dr. Sebastien Bonnet, have published the results of their research in several places including the journal "Cancer Cell".
DCA is not new - scientists and doctors have used DCA for decades to treat children with inborn errors of metabolism due to mitochondrial diseases. The mitochondria, the energy producing units in cells, have been connected to research on cancer causes since the 1930’s.
Until recently, researchers believed that cancer-affected mitochondria are permanently damaged and that this damage is the result, not the cause, of the cancer. But Michelakis, a cardiologist, questioned this belief and began testing DCA, which activates a critical mitochondrial enzyme, as a way to "revive" cancer-affected mitochondria.
The reseacrch results were astounding. Michelakis and his colleagues found that DCA normalized the mitochondrial function in many cancers, showing that their function was actively suppressed by the cancer but was not permanently damaged by it.
More importantly, they found that the normalization of the mitochondrial functions resulted in a significant decrease in tumor growth, both in test tubes and in animal trials. And even more importantly, they noted that DCA, unlike most currently used chemotherapies, did not have any effects on normal, non-cancerous tissues.
"I think DCA can be selective for cancer because it attacks a fundamental process in cancer development that is unique to cancer cells," Michelakis said. "One of the really exciting things about this compound is that it might be able to treat many different forms of cancer”.
Another encouraging thing about DCA is that, being so small, it is easily absorbed in the body, and, after oral intake, it can reach areas in the body that other drugs cannot.
Also, because DCA has been used in both healthy people and sick patients with mitochondrial diseases in the past, researchers already know that it is a relatively non-toxic molecule that can be immediately tested on patients with cancer.

”The results are intriguing because they point to the critical role that mitochondria play: they impart a unique trait to cancer cells that can be exploited for cancer therapy” ~ Dario Alteri, Director University of Massachusetts Cancer Center

“If there were a magic bullet, though, it might be something like dichloroacetate, or DCA…” ~ Newsweek, January 23, 2007

The University of Alberta, the Alberta Cancer Board and Capital Health do not condone or advise the use of dichloroacetate (DCA) in human beings for the treatment of cancer since no human beings have gone through clinical trials using DCA to treat cancer. However, the University of Alberta and the Alberta Cancer Board are committed to the clinical trials.
There is a lot of medical data out there for safe dosing levels of DCA for conditions other than cancer and a qualified and determined doctor should be able to piece together a dosing strategy. However, it is greatly recommended that people don't try this on their own. Too few people are qualified to understand their unique biochemistry (to determine if it's appropriate to a specific cancer) and dosing levels. So, you must see your physician for more information.

More information at: http://www.thedcasite.com/

http://www.youtube.com/watch?v=HMGL1LiLzWw